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Homeostatic proliferation (HSP) is a major mechanism by which long-lived naïve and
memory CD4+ T cells are maintained in vivo and suggested to contribute to the
persistence of the latent HIV-1 reservoir. However, while many in vitro latency models rely
on CD4+ T cells that were initially differentiated via T-cell receptor (TCR) stimulation into
memory/effector cells, latent infection of naïve resting CD4+ T cells maintained under
HSP conditions has not been fully addressed. Here, we describe an in vitro HSP culture
system utilizing the cytokines IL-7 and IL-15 that allows studying latency in naïve resting
CD4+ T cells. CD4+ T cells isolated from several healthy donors were infected with HIV
pseudotypes expressing GFP and cultured under HSP conditions or TCR conditions
as control. Cell proliferation, phenotype, and GFP expression were analyzed by flow
cytometry. RNA expression was quantified by qRT-PCR. Under HSP culture conditions,
latently HIV-1 infected naïve cells are in part maintained in the non-dividing (= resting)
state. Although a few HIV-1 provirus+ cells were present in these resting GFP negative
cells, the estimated level of GFP transcripts per infected cell seems to indicate a block at
the post-transcriptional level. Interestingly, neither TCR nor the prototypic HDAC inhibitor
SAHA were able to reactivate HIV-1 provirus from these cells. This lack of reactivation
was not due to methylation of the HIV LTR. These results point to a mechanism of HIV
control in HSP-cultured resting naïve CD4+ T cells that may be distinct from that in
TCR-stimulated memory/effector T cells.
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INTRODUCTION
The main obstacle to cure an HIV-1 infection is the reservoir of treatment-resistant virus-infected
cells. Current antiretroviral therapy (ART) efficiently suppresses HIV replication to undetectable
levels in plasma. However, not all of the infected cells are targeted and HIV rapidly rebounds from
this reservoir upon treatment interruption (Davey et al., 1999; Chun et al., 2000; Rosenberg et al.,
2000; Durand et al., 2012).
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The treatment-resistant reservoir consists of latently infected
cells that do not produce viral antigens such as infected resting
memory or resting naive CD4+ T cells (Eriksson et al., 2013;
Ho et al., 2013) as well as virus-producing cells that escape drug
and immune cell surveillance in sanctuary sites of the lymphatic
tissue and the central nervous system (Churchill and Nath, 2013;
Fukazawa et al., 2015). Recent evidence also suggests that the
HIV integration site into the chromosome can play an important
role in provirus expansion and persistence (Maldarelli et al., 2014;
Wagner et al., 2014). Estimates on the reservoir size were mainly
made from resting CD4+ T cells revealing very low total body
loads (Chun et al., 1997). Importantly, reservoir assessment by
means of virus outgrowth assays and HIV DNA PCR varied
by more than two orders of magnitude with less than 1% of
proviruses being susceptible to reactivation (Ho et al., 2013).
Nonetheless, more than 10% of the HIV proviruses in resting
CD4+ T cells coded for replication-competent viruses while over
80% were defective. Thus, the present virus outgrowth assays
can provide only lower estimates of the total reservoir. The
nature of the lack of reactivation of the majority of replication-
competent proviruses is unknown and an important issue both
for its assessment as part of the persistent reservoir as well as its
ability to be targeted by HIV cure strategies.
Studies on the distribution of latent HIV in different CD4+
T cell subsets demonstrated an about 10-fold higher infection
frequency of memory versus naïve T cells (Ostrowski et al., 1999;
Brenchley et al., 2004; Wightman et al., 2010; Josefsson et al.,
2013a) and a major contribution of infected central memory and
effector memory T cells to the total HIV-1 reservoir (Chomont
et al., 2009). Recently, human stem cell-like CD4+ memory T
cells (Tscm) have been described and identified as a novel HIV-1
reservoir (Buzon et al., 2014; Jaafoura et al., 2014). Tscm cells have
several phenotypic markers in common with naïve T cells (Tn)
like CD45RA+, CD27+, CD62L+, and IL7R+. Although Tn and
Tscm cells represent only minor infected T cell subpopulations,
they have the longest half-life amongst all infected CD4+ T cells
(Jaafoura et al., 2014) and can develop into central memory
and effector memory T cells upon appropriate stimuli. Thus
they represent an important component of the persistent HIV
reservoir.
Homeostatic proliferation (HSP) is a major mechanism by
which the mature naïve and memory T cell pool is maintained
in vivo (Surh and Sprent, 2008). The process relies on the
interaction of these cells with the cytokines interleukin-7 (IL-
7) and interleukin-15 (IL-15) (Boyman et al., 2012), which
trigger a signaling cascade that keep T cells, in particular naïve
T cells, mostly in a non-dividing state. Such HSP has been
suggested to contribute to the persistence of the latent HIV-1
reservoir (Chomont et al., 2009). The study, by Chomont et al.
(2009), provided evidence that high level of IL-7 in plasma from
HIV-infected aviremic individuals correlated with an increased
stability of the HIV reservoir over time. Although it was shown
that the plasma IL-15 level was not increased in HIV-infected
individuals (Chehimi et al., 1997), it is possible that IL-15 is
effective only locally or it is rapidly consumed in vivo.
As most in vitro latency models rely on CD4+ T cells first
stimulated via the T-cell receptor (TCR) and differentiated into
memory/effector cells, little is known about HIV infection of
primary naïve CD4+ T cells under homeostatic conditions. To
address this, here we used an in vitro system of HSP induced by
the cytokines IL-7 and IL-15. Under these conditions, primary
human CD4+ T cells enriched for CD45RA+ CD27+ can be
infected with HIV while maintaining their naïve phenotype.
Interestingly, our data suggest that homeostatically maintained
latently infected naïve CD4+ T cells are refractory to reactivation
through T cell receptor signaling or common latency-reversing
agents (LRAs). Together this may indicate a distinct mechanism
for HIV-1 latency maintenance in cells undergoing HSP.
MATERIALS AND METHODS
Plasmid Preparation
Based on the pNL43-derived GFP-expressing plasmid pNL-E
(Yamamoto et al., 2009), we generated a minimal lentivirus (Lenti
LTR-GFP) that expresses GFP under the control of HIV-1 LTR.
To construct the transfer vector, the pNL-E was digested with
NcoI, blunt-ended with T4 polymerase (Roche Diagnostics Inc.,
GmbH Mannheim, Germany) and further digested with BamHI.
The resulting ∼3 kb DNA fragment from 3′ part of env to the
end of LTR region of pNL-E containing EGFP-IRES-Nef with a
complete 3′ LTR. The fragment was ligated with pCDII-EF-MCS
(kindly provided by Dr. Hiroyuki Miyoshi, BioResearch Center,
Riken Tsukuba Institute, Tsukuba, Japan) at PmeI and BamHI
sites, then the Age I–Age I fragment encoding EF-1α promoter
was removed. The resulting Lenti LTR-GFP vector neither
encodes Tat nor other accessory proteins of HIV-1. Lenti EF-GFP
is the same vector as pCS-CDF-EG, one of the self-inactivating
(SIN) vectors developed by Dr. Miyoshi which consists of the
egfp gene driven by the EF-1α promoter, the rev-responsive
element (RRE), the central polypurine tract (cPPT), the central
termination sequence (CTS) and the Woodchuck hepatitis virus
Posttranscriptional Regulatory Element (WPRE). The expression
plasmid for the G protein of the vesicular stomatitis virus (VSV),
HIV-1 Rev, and the packaging plasmid pCAG-HIVgag/pol were
also provided by Dr. Hiroyuki Miyoshi. For the pseudotyped
HIV-1NL−E, Nhe I site of pNL-E was digested, blunt-ended using
a Klenow fragment (Roche Diagnostics Inc., GmbH Mannheim,
Germany) and re-ligated to generate HIV-1NL−E Menv.
Reagents
The histone deacetylase (HDAC) inhibitor SAHA (vorinostat),
2′-deoxy-5-azacytidine (dAzCyt), dimethyl sulfoxide (DMSO),
phytohemagglutinin (PHA), interleukin-2 (IL-2), staphylococcal
enterotoxin B (SEB) and DNase I were purchased from Sigma-
Aldrich (St. Louis, MO, USA). An integrase inhibitor, Raltegravir
(RAL) was obtained from Selleck Chemicals (Houston, TX,
USA). Purified anti-human CD3 and CD28 were purchased from
eBioscience (San Diego, CA, USA).
Virus Production and Titration
Viruses were prepared as described previously (Yamamoto
et al., 2006a). In brief, HEK293T cells in 15 cm dishes were
co-transfected with respective plasmids by the calcium phosphate
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method. Six to eight hours after transfection the culture
supernatant was replaced with a fresh DMEM containing L-
glutamine, antibiotics, 5 mM MgCls and 100 U of DNase I.
Virus-containing supernatant was collected at 40–48 h later,
clarified by centrifugation (2500 rpm for 20 min) and kept
frozen at −80◦C. Virus was concentrated by ultracentrifugation
at 28,000 rpm for 2 h at 4◦C using SW34Ti rotor and
Optima L-90K (Beckman-Coulter, Inc., Fullerton, CA, USA).
Gag p24 amounts in supernatants were measured by an in-
house HIV-1 Gag p24 enzyme-linked immunosorbent assay
(ELISA; Tsunetsugu-Yokota et al., 1995). According to the
GFP-expressing frequency in lentivirus infected CEM cells we
determined that MOI = 1 was achieved by adding 1 µg of p24
amount to 106 cells.
Cells and Virus Infection
HEK293T cells and CEM cells were maintained in DMEM
and RPMI-1640, respectively, supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 100 g/ml
penicillin/streptomycin (Invitrogen, San Diego, CA, USA)
and 2 mM L-glutamine. Peripheral blood mononuclear cells
(PBMCs) were isolated from healthy donors after obtaining
written informed consent. Sample collection was approved by
the Ethical Committee of the National Institute of Infectious
Diseases (NIID, Tokyo, Japan), where the experiment was carried
out. Human T cells were first negatively enriched from PBMCs
using the EasySepTM Human T cell enrichment kit (StemCell
Technologies, Vancouver, BC, Canada). CD4+ T cells were
further purified from T cells using the EasySepTM human CD4+
T cell enrichment kit. In some experiments, naïve CD4+ T
cells were enriched using the EasySepTM human naïve CD4+
T cell enrichment kit (StemCell Technologies, Vancouver, BC,
Canada). Purified CD4+ T cells were labeled with 1 µM of CFSE
or CellTraceTM Violet (Violet tracer) stain kit (Invitrogen, San
Diego, CA, USA) in warm PBS at 37◦C for 20 min, washed and
pulsed with 10% FBS+RPMI for 15 min. For virus infection,
cells were either mock infected or infected with lentiviruses by
spinoculation at room temperature, 2800 rpm for 2 h (Swiggard
et al., 2005). If not stated otherwise, cells were infected with
viruses at a MOI of around 1. Cells were washed 3 times and
cultured in 10% FBS+RPMI supplemented with 5% human
serum, IL-7 and IL-15 (PeproTech, London, UK) at 10 ng/ml
each. A part of cells were activated using plate-coated anti-CD3
mAb (5 µg/ml) and anti-CD28 mAb (1 µg/ml) in 10% RPMI
containing 40 U IL-2. In some experiments, monocyte-derived
dendritic cells (MDDC) from the same donor were prepared
as described previously (Yamamoto et al., 2009), pulsed with
SEB antigen at 100 ng/ml, and cocultured with CD4+ T
cells.
RNA Extraction and Quantitative RT-PCR
RNA was extracted using PureLink RNA Mini Kit (Life
Technologies, Carlsbad, CA, USA), and cDNA was synthesized
by using SuperScript VILO Master mix (Life Technologies,
Carlsbad, CA, USA) according to the protocol by the company.
The cDNA product was then mixed with 10 µl of polymerase
mixture (Eagle Taq Master Mix kits: Roche Diagnostics Inc.,
GmbH Mannheim, Germany), 0.5 µl each of 10 µM primers
and 5 µM TaqMan probe in a total volume of 20 µl.
The PCR was performed using the Mx3000P qPCR system
(Stratagene, La Jolla, CA, USA). The PCR reaction was
set as 40 cycles of 60◦C for 15 s, and 95◦C for 15 s
after a 10 min denaturing step at 95◦C. The following
primers and probes for a TaqMan assay were used: EGFP-2F,
5′-gaccactaccagcagaacac-3′, EGFP-2R, 5′-gaactccagcaggaccatg-3′,
probe, [6-FAM] agcacccagtccgccctgagca [BHQ-1], RNase P-F,
5′-agatttggacctgcgagcg-3′, RNase P-R, 5′-gagcggctgtctccacaagt-
3′, probe, [6-FAM] ttctgacctgaaggctctgcgcg [BHQ-1]. For the
detection system by Sybr Green, cDNA was mixed with 10 µl
of Platinum Taq two-step Sybr qRT-PCR solution (Invitrogen,
San Diego, CA, USA), 0.5 µl each of 10 mM primers and
0.5 µl of Rox dye in a total volume of 20 µl according to
the protocol from the company. First incubation for 30 min
at 50◦C, followed by 40 cycles of 15 s at 95◦C, 15 s at 60◦C
and 15 s at 70◦C and finally 5 s at 60◦C and 5 s at 95◦C. The
primers used were: Hs-SAMHD1-F, 5′-tcgtccgaatcattgatacacc-3′,
Hs-SAMHD1-R, 5′-gtgcgtgaactagacatcctg-3′, hA3G-rtp-S, 5′-cg
cagcctgtgtcagaaaag-3′, hA3G-rtp-A, 5′-ccaacagtgctgaaattcgtcata-
3′. EF-1α 294F, 5′-gaacagttgggtcgctttgctgttc-3′, EF-1α 307R,
5′-gacacccaccgcaactgtct-3′. The primer sets of EF-1α and
RNase P were used for the endogenous gene expression as a
reference.
HIV Integration Assay
Genomic DNA from collected cell samples was extracted using
a QIAamp DNA Micro Kit (Qiagen, Valencia, CA, USA). The
copy number of integrated viral DNA was measured according
to the real-time nested Alu-HIV PCR assay (Yamamoto et al.,
2006b) with some modifications. During the first-round PCR,
Alu-gag sequences were amplified in a 25 µl reaction mixture
containing extracted DNA, 1x High Fidelity PCR buffer
(Invitrogen, San Diego, CA, USA), 0.2 mM mixed dNTPs, 2 mM
MgSO4, 200 nM of the Alu-1 primer (5′-tcccagctactggggag
gctgagg-3′; Brussel and Sonigo, 2003), 200 nM of the
Alu-2 primer (5′-gcctcccaaagtgctgggattacag-3′; Brussel
and Sonigo, 2003), 200 nM of the first-gag-R primer (5′-
caatatcatacgccgagagtgcgcgcttcagcaag-3′), and one unit of a
Platinum Taq DNA Polymerase High Fidelity (Invitrogen
San Diego, CA, USA). The first-round PCR condition was
as follows: a DNA denaturation step of 2 min at 94◦C and
then 20 cycles of amplification (94◦C for 30 s, 50◦C for 30 s,
68◦C for 100 s) on a TaKaRa PCR Thermal Cycler Dice
(Takara, Japan). Note that the first-round PCR efficiency is
affected by the number of Alu sites (Agosto et al., 2007).
Therefore, the amount of total DNA was adjusted to be
1 × 105 copies of β-globin to maintain the number of Alu
sites. If the amount of sample DNA was <1 × 105 copies
of β-globin, DNA extracted from CEM cells was added.
The copy number of β-globin was determined by real-
time PCR using a primer set (forward, 5′-caagaaagtgctcggtg
cctt-3′; reverse, 5′-cctgaagttctcaggatccacg-3′) and a probe
(FAM-5′-acactgagtgagctgcactgtga-3′-BHQ-1) with the Mx3000P
qPCR System (Stratagene, Amsterdam, The Netherlands). The
second-round PCR was performed in a 25 µl reaction mixture
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containing 1 µl of the first-round PCR product, 1x EagleTaq
Master Mix (Roche Diagnostics Inc., GmbH Mannheim,
Germany), 100 nM of the U5 primer (5′-ccgtctgttgtgt
gactctgg-3′; Suzuki et al., 2003), 100 nM of the second-
tag-R primer (5′-caatatcatacgccgagagtgc-3′; Suzuki et al.,
2003), and 50 nM of the second PCR probe (FAM-5′-
cgcttcagcaagccgagtcctgc-3′-BHQ-1). The second-round PCR
condition was as follows: a DNA denaturation and polymerase
activation step of 10 min at 95◦C and then 40 cycles of
amplification (95◦C for 15 s, 60◦C for 1 min) on a Mx3000P
qPCR system. A standard curve was prepared by using a serial
dilution of DNA extracted from ACH-2 cells, which contain one
copy of HIV-1 provirus per genome.
The amount of integrated viral DNA per cell was calculated
by using the copy number of β-globin (two copies per diploid
cell) as reference. For the calculation of a provirus copy
number, a part of CD4+ T cells were pretreated with RAL for
30 min and infected in the presence of RAL to discriminate
the genuine integration from contaminating unintegrated viral
DNAs.
Methylation Analysis
CpG DNA methylation within the LTR was analyzed by
bisulfite sequencing. Genomic DNA from the each sorted
population was subjected into MethylEasy Xceed Rapid DNA
Bisulphite Modification kit (Human Genetic Signatures,
NSW, Australia). PCR primers for the modified DNA
were as follows: Fw, 5′-tttgttatattttgtgagtttgtat-3′; Rv, 5′-
acaactacttatatacaacatcta-3′. Resulting amplicons were TA-cloned
into the pGEM-T easy vector (Promega), followed by DNA
sequence analysis.
Flow Cytometry
The markers for T-cell activation and proliferation were analyzed
by a FACScanto II (BD Biosciences, Heidelberg, Germany) flow
cytometer. Antibodies used in this study were: PerCP-labeled
anti-human CD4 (clone RPA-T4), PE-Cy7 labeled anti-human
CD45RA (clone HI100), Alexa Fluor 700-labeled anti-CD27
(clone O323), FITC-anti-human CD25 (BC96), all purchased
from (BioLegend, San Diego, CA, USA). Alexa Fluor 647-
labeled anti-human CD11a (LFA-1: TS1/22.1.1.13) was prepared
from hybridoma cells (ATCC No. HB 202) and conjugated
using Alexa Fluor succinimidyl esters (Invitrogen, Carlsbad, CA,
USA). Dead cells were stained with a LIVE/DEAD Fixable Dead
Cell Stain Kit (L34957, Invitrogen, Carlsbad, CA, USA) and
were gated out during analysis. For cell sorting, a FACSaria
II cytometer was used. The data were analyzed by FACSdiva
software and reanalyzed by Flowjo ver 8.8.7 (Tree Star Inc., CA,
USA).
Statistical Analysis
For the statistical analysis, Prism software ver. 5.0 (GraphPad
Software Inc., San Diego, CA, USA) was used. The non-
parametric two-tailed paired t-test (Wilcoxon matched-pairs
signed rank test) was applied for the evaluation of statistical
difference of two groups.
RESULTS
Homeostatic Proliferation Maintains the
Phenotypic State of Naïve CD4+ T Cells
In vivo the T cell pool under cytokine-driven homeostasis
remains largely unchanged (Chomont et al., 2009). To
characterize the proliferation and phenotype status of T
cells undergoing HSP, primary purified CD4+ T cells were
cultured in the presence of both IL-7 and IL-15 (designated here
as HSP culture) or stimulated via the TCR using immobilized
anti-CD3 and anti-CD28 in the presence of IL-2 (designated
as TCR culture) as control. We considered CD45RA+/CD27+
CD4+ T cells as naïve and CD45RA−/CD27+ as early memory
cells. Under HSP culture conditions, CFSE-labeled non-dividing
( = resting) CD4+ T cells were activated (CD11a expression)
and the cells were able to gradually proliferate (Figure 1A,
upper panel), whereas under TCR culture conditions most of
the cells proliferated vigorously and lost the CFSE dye at day
12 (Figure 1A, lower panel). Similarly to a previous report by
Unumatz et al. (1999), the proportion of resting CD4+ T cells
with a naïve phenotype was maintained during the time of HSP
culture (Figure 1B). This pattern of HSP was observed in several
donors (data not shown) and make HSP culture a suitable system
to analyze the natural process of HIV infection of naïve CD4+ T
cells in vitro.
HSP and TCR Culture Conditions
Differentially Affect HIV LTR-Dependent
Expression of a GFP Marker Gene in
Infected CD4+ T Cells
The structures of all HIV-1 pseudotype viruses (HIVpp) used in
this study are illustrated in Figure 2A. First, in order to analyze
HIV-1 infection under HSP conditions, we infected CD4+ T cells
with two minimal lentiviral vectors encoding a GFP marker gene
under the control of either the HIV-1 LTR (Lenti LTR-GFP) or the
EF-1α promoter (Lenti EF-GFP) (Figure 2A). The experimental
strategy is outlined in Figure 2B. Briefly, unstimulated CD4+
T cells purified from blood of healthy donors were labeled
with a Violet tracer dye, and infected with Lenti LTR-GFP or
Lenti EF-GFP pseudoviruses by spinoculation. Infected cells were
cultured under HSP or TCR culture conditions, and both the
proliferation and GFP expression were monitored at days 0, 4,
and 7 by flow cytometry. Figure 2C shows the proliferation
and GFP expression profiles at day 4. Around 20% of Lenti
EF-GFP-infected CD4+ T cells expressed GFP in TCR cultures,
whereas only 8.1% of them expressed GFP under HSP conditions
(Figure 2C, upper panels). However, the percentage of GFP-
expressing CD4+ T cells in HSP culture increased to 24.6% at
day 7 (data not shown), suggesting that HIVpp transcription
progresses slowly in these cells. In comparison, the frequency of
GFP-expressing cells in Lenti LTR-GFP-infected CD4+ T cells
was lower in both culture conditions with a difference of around
10-fold between HSP (0.15%) and TCR conditions (1.75%)
(Figure 2C, lower panel). To assess whether the lower frequency
of GFP+ cells after Lenti LTR-GFP infection in HSP compared
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FIGURE 1 | Characterization of homeostatic proliferation of primary human CD4+ T cells. Primary CD4 T cells were purified from PBMC of healthy donors,
labeled with CFSE and cultured under homeostatic conditions with 10 ng/mL of both IL-7 and IL-15 (HSP culture). As controls, CD4 T cells were stimulated with
plate-coated anti-CD3 mAb at 5 µg/mL and 1 µg/mL anti-CD28 mAb, and kept in culture in the presence of 40U IL-2 (TCR culture). At days 5 and 12, cells were
collected, stained with PerCP-CD4, PE-Cy7-CD45RA, Alexa Fluor 700-CD27, and Alexa Fluor 647-CD11a, and analyzed by flow cytometry. Live and CD4-positive
cells were gated. Dot plots of CD11a expression against CFSE are shown for HSP culture and controls (A). The majority of cells under homeostatic culture
conditions as opposed to the TCR-stimulated control population remained in a naive phenotype as judged by CD27 and CD45RA expression (B). Percentages of
naïve cells are given.
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to the TCR culture could be attributed to distinct integration
efficiencies in the two culture systems, we analyzed by Alu-PCR
proviral copy numbers of Lenti LTR-GFP-infected CD4+ T cells
at days 0, 3, 5, and 7 after culturing under HSP or TCR conditions
in the presence or absence of the HIV integrase inhibitor RAL.
As previously described (Swiggard et al., 2005), the integration
process progressed slowly in primary CD4+ T cells. Figure 2D
shows the results representative of seven donors. We observed
no clear differences in the provirus copy numbers per cell basis
between the two culture conditions. Our values are in the same
range as those found by others and are in the order of 60-fold
higher than seen in patient samples (Chomont et al., 2009; Buzon
et al., 2014). The presence of RAL efficiently reduced the copy
number in each time point, indicating that genuine integration
efficiency was monitored. Taken together, these results indicate
that the HIV-1 LTR is mostly restricted at a transcriptional level
in both HSP and TCR conditions, with HSP-cultured CD4+ T
cells receiving stronger restriction than TCR-cultured cells.
Lack of GFP Expression from Infected
Resting CD4+ T Cells upon TCR
Stimulation Is Not Due to SAMHD1- or
APOBEC3G-Mediated Restriction
To analyze HIV transcriptional activity in cells undergoing
HSP, CD4+ T cells were infected with Lenti LTR-GFP and
cultured under HSP conditions as depicted in Figure 3A. Eleven
to fifteen days after infection, total GFP+ cells (Figure 3B,
upper square) and GFP−/resting cells (Figure 3B, lower square)
were sorted by flow cytometry. GFP mRNA transcript levels
in the sorted cell populations were analyzed by qRT-PCR.
Figure 3C shows the levels of GFP transcripts relative to
that of endogenous EF-1α transcripts from sorted GFP+ and
GFP−/resting cells (mean of five different donors). Although
the GFP mRNA levels in the GFP+ fraction was around
10-fold higher, GFP transcripts from GFP−/resting CD4+
T cells were also detectable. These latter cells harbored an
estimated 0.012 to 0.032 proviral copies per cell (mean = 0.02,
SD = 0.01, n = 5). Supposing a proviral copy number of
one in the GFP+ fraction (Figure 3C left column), roughly
50-fold less provirus-positive cells should be present in the
GFP−/resting fraction (Figure 3C right column). Based on
the determined transcript levels, this would correspond to a
fivefold higher GFP transcript level per provirus containing
GFP−/resting cell. Nonetheless, there was no GFP expression
detectable by flow cytometer. This may be indicative of a
translational block of provirus expression in GFP−/resting CD4+
T cells.
To investigate whether the apparent low level of HIV
transcriptional activity observed in resting HSP cultured cells was
correlated to an upregulation of the restriction factors SAMHD1
and/or APOBEC3G (Chiu et al., 2005; Laguette et al., 2011) we
quantitated transcripts of these genes in the sorted GFP+ and
GFP−/resting CD4+ T cells from three donors by qRT-PCR.
CEM T cells were used as control. No significant difference in
SAMHD1 (Figure 3D) nor in APOBEC3G (Figure 3E) RNA
levels was observed between GFP−/resting and GFP+ CD4+ T
cells (P = 0.6406 and 0.2969, respectively, n = 7). This suggest
that the apparent low levels of HIV transcripts observed in
GFP−/resting CD4+ T cells are not due to the action of these
restriction factors.
Finally, in order to study the reactivation potential of the
lentivirus vectors, infected GFP−/resting CD4+ T cells were
sorted ∼15 days after HSP culture and TCR-stimulated by
co-culturing with dendritic cells pulsed with the SEB antigen
(SEB-pulsed DCs) or left untreated. Sorted resting CD4+ T
cells became highly activated and vigorously proliferated during
72 h (Figure 3F), however, no increase of GFP+ cells could
be detected. No significant changes were observed in cells
cultured further for 7 days (data not shown). Interestingly,
we observed a decrease of GFP transcripts relative to that
of EF-1α in TCR-stimulated cells compared to untreated
cells (Figure 3G). The decrease in relative GFP transcripts
after DC/SEB stimulation is likely due to the increase of
endogenous cellular mRNA species including the reference
gene (EF-1α) after TCR activation. Identical results were
obtained by TCR stimulation of HSP-cultured resting CD4+
T cells from two additional donors. Taken together, despite
the fact that the resting CD4+ T cells in HSP culture harbor
integrated proviral genomes and express low levels of GFP,
LTR-driven mRNA expression is either specifically suppressed
by yet unknown mechanisms or remains unresponsive to TCR
stimuli.
Total and Naïve HSP-Cultured CD4+ T
Cells Support Productive HIV-1NL−E
Infection
The HIV-1 Tat protein is known to regulate the transcriptional
activity of the HIV LTR promoter (Donahue et al., 2012). As
the Lenti LTR-GFP vector did not encode accessory genes,
including tat, only the basal promoter activity was assessed in
the experiments described in Figures 2 to 3. To test the effect
of HSP culture conditions in the context of an HIV genome
that contains all accessory proteins including Tat, we used the
parental HIV-1NL−E construct as shown in Figure 2A. Briefly,
purified CD4+ T cells from two healthy donors were infected
with HIV-1NL−E virus at MOI = 0.2, cultured in HSP culture
and analyzed for proliferation and GFP expression by flow
cytometry at day 11 before virus-induced cytopathic effect (CPE)
became apparent (Figure 4A). Approximately 5% of total CD4+
T cells expressed GFP, with half of these being in a resting state
(1.9% in donor 1 and 2.4% in donor 2, Figure 4B). Around
50% from the total CD4+ T cells corresponded to the naive
phenotype (CD45RA+CD27+, as defined earlier), similar as in
Figure 1B. When naïve CD4+ T cells were gated, 0.68 and
1.13% of resting cells in donor 1 and donor 2, respectively,
were GFP+ (Figure 4C). In HIV-1NL−E-infected cells, resting
CD4+ T cells expressing GFP were more abundant (1.91∼2.4%
in ∼5% of total GFP+ cells in Figure 4B) compared to those
in Lenti LTR-GFP-infected cells (0.38% in 3.7% of total GFP+
cells in Figure 3B). This suggests that the ongoing replication
cycles of a wild-type HIV-1NL−E enhances the infectivity of HSP-
cultured resting CD4+ T cells with both naïve and memory
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FIGURE 2 | HIV LTR-dependent expression of a GFP marker gene is differentially influenced by HSP and TCR culture of lentivirus-infected CD4+ T
cells. (A) Structure of the parental GFP-expressing HIV-1NL−E vector and its derivatives used in this study: HIV-1NL−E−1Env, Lenti LTR-GFP (encoding LTR-driven
GFP) and Lenti EF-GFP (encoding EF-1α promoter-driven GFP). Plasmid names used for co-transfection for virus production are given. See “Materials and Methods”
for details on vector generation. (B) Experimental strategy outline. Purified, unstimulated, Violet tracer-labeled CD4+ T cells were spinoculated with Lenti LTR-GFP or
Lenti EF-GFP, and cultured under HSP or TCR conditions. (C) EF promotor- or LTR-driven marker gene expression under HSP culture or TCR conditions. Infected
and cultured cells were analyzed for GFP expression and proliferation (Violet Tracer) at day 4 by flow cytometry (HSP culture; left panel and TCR culture; right panel).
A representative plot from four different donors is shown. (D) Lentivirus-infected CD4+ T cells show similar levels of vector integration under HSP and TCR culture
conditions. CD4+ T cells were infected as under (B), cultured in the presence or absence of integrase inhibitor Raltegravir (RAL) and collected at days 0, 3, 5, and 7.
The level of vector integration was analyzed by Alu-PCR. The copies per cell are shown for all time points tested.
phenotype. It is also possible that the presence of Tat enhanced
the GFP expression driven by the LTR promoter in HIV-1-
integrated resting CD4+ T cells. In contrast, massive HIV-1
infection and higher level of GFP expression were evident in
TCR-proliferated CD4+ T cells at day 8 p.i. (Figure 4D, left) but
the frequency of HIV-1-infected cells was substantially decreased
at day 11 p.i (Figure 4D, right) because of the strong CPE of
HIV-1.
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FIGURE 3 | The impairment of the HIV marker gene expression (GFP) in
HSP-cultured resting CD4+ T cells is not linked to increased levels of
SAMHD1 or APOBEC3G, and is not induced upon TCR engagement by
antigen-pulsed dendritic cells. (A) Outline of experimental strategy. Violet
tracer-labeled CD4+ T cells were infected with Lenti LTR-GFP and cultured
under HSP conditions for 11–15 days. GFP-positive and resting GFP-negative
cells were sorted by preparative flow cytometry as marked in the analytical dot
plot (B). Total RNA from both cell populations was isolated, reverse
transcribed with random hexamers and subjected to quantitative PCR specific
for GFP (C), SAMHD1 (D), and APOBEC3G (E) transcripts. RNA isolated from
CEM cell lysates was used as control for SAMHD1 and APOBEC3G
transcripts. Transcript levels were normalized to endogenous EF-1α (C) or
RNase P (D,E) mRNA levels. For panels (F,G), resting GFP-negative cells were
sorted by preparative flow cytometry and cultured in HSP conditions (HSP), or
the presence of SEB-pulsed DCs (DC/SEB). Cell proliferation (Violet tracer)
and GFP expression were analyzed by flow cytometry after 48 or 72 h (F).
GFP transcripts were analyzed by quantitative RT-PCR from isolated total RNA
(G). Transcripts levels were normalized to endogenous EF-1α mRNA levels.
FIGURE 4 | Total and naïve, HSP-cultured CD4+ T cells are both
susceptible to productive HIV infection. (A) Outline of experimental
strategy. Violet tracer-labeled CD4+ T cells from two blood donors were
infected with a wild-type HIV-1NL−E and cultured under HSP conditions for
11 days. GFP expression and proliferation were analyzed by flow cytometry.
(B) Total CD4+ T cells. (C) CD45RA+CD27+ naïve CD4+ T cells. (D) As a
control, violet tracer-labeled total CD4+ T cells were infected with HIV-1NL−E,
TCR stimulated with anti-CD3 and anti-CD28, and cultured in the presence of
IL-2. Cells were analyzed by flow cytometry at 8 days (left panel) or 11 days
(right panel) post infection. Percentages of GFP-positive cells are given for the
proliferated and resting cell populations.
The Latency-Reversing Agent Vorinostat
(SAHA) Is Able to Reactivate HIV Provirus
in TCR- But Not in HSP-Cultured CD4+ T
Cells
Next, we investigated the effect of various reactivation stimuli
on the latent infection, in particular, of resting naïve CD4+ T
cells maintained under HSP conditions. For this, naïve-enriched
CD4+ T cells from healthy donors were infected with HIV-
1NL−E−1Env/VSV-G and cultured for 11–13 days under HSP
or TCR conditions (Figure 5A). The frequency of total GFP+
cells in the pseudotyped HIVNL−E infection was around 1% with
only a few positive cells being detectable in the resting naïve
CD4+T cell fraction (Figure 5B, representative of several donors
at 11 days post infection). The GFP−/resting cells were sorted
(Figure 5B, enclosed square) and cultured further under HSP
conditions or activated either with anti-CD3 and anti-CD28,
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FIGURE 5 | The HIV-1 provirus is refractory to reactivation in resting,
latently infected HSP-cultured CD4+ T cells in spite of lack of
extensive LTR methylation. (A) Outline of experimental strategy. Violet
tracer-labeled, naïve CD4+ T cells were infected with VSV-G protein
pseudotyped HIV-1NL−E−1Env (HIV-1NL−E−1Env/VSV-G) and cultured under
HSP or TCR conditions for 11–13 days. GFP-negative, resting cells from the
HSP culture (marked in square) were sorted by preparative flow cytometry as
shown in the representative dot plots (B). Sorted cells were subjected to
various stimuli for 2 days, lysed and the GFP mRNA subjected to quantitative
RT-PCR. Transcripts levels were normalized to endogenous RNase P mRNA
levels. (C) In parallel, cells from the TCR culture were treated with SAHA or left
without, and were tested for GFP expression by flow cytometry (D), and for
GFP transcript levels by quantitative RT-PCR (E). Sorted cells as in (B) from
three blood donors were subjected to methylation analysis of the LTR region
(F). In two of the three donors, no LTR site was methylated [F(1)] while a few
sites were methylated in one donor [F(2)].
phytohaemagglutinin (PHA), the HDAC inhibitor Vorinostat
(SAHA) or the methylation inhibitor 5-Aza-2′-deoxycytidine
(dAzCyt). Both SAHA and dAzCyt are commonly used as
reactivators in many in vitro HIV latency models (Kauder et al.,
2009; Friedman et al., 2011; Ho et al., 2013). Two days after
stimulation, total RNA was isolated from the cells and the relative
amounts of GFP mRNA were analyzed by qRT-PCR (Figure 5C).
Here, we chose RNase P as a reference gene because it is known
to be a good internal, low copy number mRNA control suitable
for qRT-PCR analysis in various tissues (Ikeno et al., 2013).
Strikingly, we observed no increase in the relative GFP transcript
levels in treated cells compared to untreated cells (Figure 5C).
This suggests that the reactivation of HIV-1 is not achievable by
these strong stimuli in HSP-cultured resting naïve CD4+ T cells.
As a control, infected naïve CD4+ cells were TCR-stimulated
and maintained in the presence of IL-2 for 13 days. These T
cells were cultured for additional two days in the absence or
presence of SAHA, and GFP expression was analyzed by flow
cytometry as well as by qRT-PCR (Figures 5D,E, respectively).
The representative FACS results of one of two donors are shown
in Figure 5D. Compared to untreated controls, addition of
SAHA resulted in a sixfold increase in the number of GFP+
cells (Figure 5D), which correlated with a sevenfold increase
in the relative GFP mRNA levels (Figure 5E). These results
are consistent with those reported by others that HIV-1 in
resting memory/effector cells that were initially TCR-activated
and returned to the resting state could be reactivated by SAHA.
Taken together, our results suggest that HIV-1 latency may be
maintained in HSP-cultured resting naïve CD4+ T cells by a
different mechanism from that in TCR-cultured resting memory
CD4+ T cells.
Lack of Epigenetic Methylation of the
HIV-1 LTR in Resting HSP-Cultured CD4+
T Cells
Methylation at the HIV-1 LTR promoter may influence its
transcriptional activity. Thus, we analyzed the methylation status
of the integrated HIV-1 LTR in sorted resting naïve CD4+ T cells
of 3 donors cultured under HSP culture conditions (Figure 5A).
The results are shown in Figure 5F. Two donors showed no
methylation in the U3 region of the LTR [Figure 5F(1)], whereas
the remaining donor exhibited methylation only at a few sites
[Figure 5F(2)]. These results suggest that the methylation status
of the LTR is not the cause for the lack of HIV reactivation in
resting naïve CD4+ T cells.
DISCUSSION
Perhaps the most striking finding of our work is the observation
that HIV-1 proviruses in homeostatically maintained resting
naïve CD4+ T cells are not reactivated by TCR-mediated
signaling. Latently infected naïve T cells represent only a minor
component of the total HIV reservoir in infected individuals,
however, they have a very long half-life and can feed the pool
of infected memory T cells. Identifying the physiological signals
under which these cells may produce infectious virus is therefore
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utterly important for curative therapy strategies. Our data now
suggest that there may exist a unique mechanism of blocking
provirus reactivation that requires other or additional signals
for HIV propagation than in infected memory T cells. There
remains the possibility that provirus+ T cells are preferentially
lost during 24–48 h cultivation especially when massive T
cell-proliferation was induced by TCR stimulation as shown
in Figure 3F. However, in the case of the HDAC inhibitor
SAHA, cells were not proliferating, and no increase of GFP
protein (data not shown) and GFP mRNA (Figure 5C) was
observed. In contrast, the same amounts of HIV-loaded CD4+
T cells maintained in TCR culture clearly express GFP protein
and transcripts after SAHA stimulation (Figures 5D,E). As we
described in the result of Figure 3C, GFP transcripts per one
proviral copy in GFP−/resting CD4+ T cells was calculated to
be about fivefold higher than that in GFP+ cells. This indicates
that a translational block may occur in GFP−/resting CD4+ T
cells. In this line, Mohammadi et al. (2014) suggests that post-
transcriptional blocks contribute to latency in their primary cell
model. Taken all together, we conclude that provirus containing
naïve resting CD4+ T cells do not respond to reactivation stimuli
with encoded protein expression.
HIV-1 proviruses were refractory to reactivation by the HDAC
inhibitor SAHA in the HSP-maintained naïve CD4+ T cell
fraction. However, recent observations by others suggest that
HIV latency in resting CD4+ T cells may be reversed through
NF-kB signaling (Saleh et al., 2016) or latency reversing agents
(Zerbato et al., 2016). These studies are based on resting CD4+
T cells pre-treated with the CCR7-ligand CCL19 which activates
phosphatidylinositol 3-kinase (PI3K) and phospholipase C (PLC)
pathways (Evans et al., 2012) increasing permissiveness of
HIV infection in these cells (Saleh et al., 2007). Thus, the
reactivation discrepancy between these studies and ours may
be partly explained by the fact that their “resting cells” are
not necessarily non-dividing cells. In addition, it has been
recently shown that HIV integration efficiency is higher in
IL-7-treated than in CCL19-treated CD4+ T cells (Chavez et al.,
2015), and that IL-7-treated CD4+ T cells do not induce
NFAT or PI3K signaling (Ducrey-Rundquist et al., 2002). Taken
together, it seems likely that these different stimuli support
distinct intracellular environments that differentially affect HIV-1
infection and latency reversal.
The main drivers of HSP are the cytokines IL-7 and IL-15,
which signal through the Janus kinase-signal transducer and
activator of transcription pathway (JAK-STAT). This leads to
differential expression of several molecules that participate in the
regulation of cell proliferation and apoptosis (Mackall et al., 2011;
Jabri and Abadie, 2015). Ducrey-Rundquist et al. (2002) speculate
about the role of the JAK-STAT pathway for HIV permissiveness
in IL-7 treated CD4+ T cells. However, whether such cellular
factors along the JAK-STAT pathway might be playing a direct
role in suppressing LTR-mediated HIV expression cells remains
to be explored.
Quantitative reservoir assessment by qPCR demonstrated that
the majority of latently infected T cells are within the memory
cell population which outnumber infected naïve T cells by
about 10-fold (Chomont et al., 2009; Josefsson et al., 2013a,b).
Nonetheless, naïve T cells have a very long half-life and can
survive as resting cells for extended periods of time (McCune
et al., 2000; Vrisekoop et al., 2008). Furthermore, they are also
maintained by low-level activation and HSP (Surh and Sprent,
2008). This low activation level may translate to a low level of HIV
expression that is insufficient for dying through virus-mediated
CPEs and immune surveillance but sufficient for feeding the
pool of latently and productively infected cells. Indeed, the HIV
burst size of experimentally infected naïve T cells reincorporated
into a human tonsil culture was about eightfold lower than that
of memory T cells (Eckstein et al., 2001). In addition, HIV-
producing naïve CD4+ T cells have been detected in lymph nodes
by in situ hybridization (Zhang et al., 1999), and, under special
conditions of an acute SHIV infection of macaques, naïve CD4+T
cells represent the majority of infected CD4+T cells (Nishimura
et al., 2009). Thus, HIV-1-infected naïve T cells represent a
relevant component of the latent reservoir.
Current in vitro HIV latency-reactivation models are mainly
based on TCR-stimulated resting memory/effector CD4+ T cells
(Sahu et al., 2006; Marini et al., 2008; Tyagi et al., 2010), and
the reactivation of latent HIV-1 in resting naïve CD4+ T cells
undergoing HSP has not been further investigated. Here, we
describe an in vitro culture system of HSP that allows studying
HIV-1 latency in naïve CD4+ T cells. We show that cells infected
with a GFP-encoding HIV-1 and cultured under HSP conditions
were maintained in a non-dividing ( = resting) state. Only a
small fraction of GFP+ cells were detected compared to those
observed in TCR-stimulated memory cells despite that HIV-1
integration and GFP mRNA was detectable in naïve CD4+ T
cells. Interestingly, neither TCR nor chemical stimuli like SAHA
were able to reactivate HIV-1 provirus in HSP-cultured naïve
CD4+ T cells. Our results suggest that this lack of activity is
not due to an increased expression of the restriction factors
SAMHD1 or APOBEC3G, nor to the methylation status of the
LTR. These observations are in agreement with a recent report
by Coiras et al. (2016) showing that IL-7 treatment of CD4+ T
cells induces SAMHD1 phosphorylation abrogating its antiviral
activity. Although additional epigenetic regulation cannot be
ruled out, altogether these results point to a mechanism of HIV
control in resting naïve CD4+ T cells that may be distinct from
that in TCR-stimulated memory/effector CD4+ T cells.
Antigen-dependent TCR activation of CD4+ T cells is the
most efficient stimulus for productive HIV-1 infection in vivo.
In an antigen-independent culture system containing IL-2,
Woods et al. reported that CD45RA+ naïve CD4+ T cells
easily lose HIV-1 productivity after entry (Woods et al., 1997)
suggesting that HIV-1 requires cellular activation signals beyond
that provided by IL-2 alone. It has been argued that HIV-1
enter resting naïve cells less efficiently than memory cells (Dai
et al., 2009), and that VSV-pseudotyped HIV cannot fuse or
establish latent infection in unstimulated, resting CD4 T cells
(Agosto et al., 2009; Yu et al., 2009). However, other studies
have shown that VSV-pseudotyped HIV was able to integrate
into both naïve and memory resting CD4+ T cells mixed
with dendritic cells at similar efficiencies (Dai et al., 2009).
While we did not discriminate the Lenti LTR-GFP integration
kinetics between naïve and memory T cell infection, we show
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here that naïve cells were able to express a substantial level
of viral RNA even 2 weeks after VSV-pseudotyped HIV-1
infection. This indicates that the infection process of resting naïve
CD4+ T cells successfully progressed by cytokine stimulation
immediately after spinoculation. However, whether antigen-
independent activation by cytokines favorably supports latent
HIV infection or permanently suppresses integrated HIV-1
remains to be addressed.
In summary, here we show that HIV-1 integration and
transcription were detectable in resting naïve CD4+ T cells
cultured under HSP. HSP-cultured cells slowly proliferated
and maintained their naïve phenotype. Interestingly, latently
infected resting naïve cells kept under these conditions were
reactivation resistant. The nature of this apparent lack of
reactivation is unknown but may relate to stochasticity of
HIV promoter activation or present a distinct mechanism of
provirus silencing related to the HSP maintenance process in
different T cell subsets. The latter seems to be reinforced by a
recent report suggesting that the efficiency of latency reversing
agents may be T cell phenotype-dependent (Baxter et al., 2016).
Currently, however, we cannot eliminate the possibility that
all proviral DNAs in naïve resting CD4+ T cells exist as
defective proviruses and, therefore, will never be replication-
competent. Altogether, given the contribution of naïve CD4+
T cells to the latent HIV reservoir in vivo, our results and
those of others, warrant further studies on HIV reactivation
in latently infected cells that are maintained by homeostatic
mechanisms.
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